NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM2650022 Query DataSets for GSM2650022
Status Public on May 31, 2018
Title LNCaP parental PD treated replicate 3
Sample type SRA
 
Source name human prostate cancer cells
Organism Homo sapiens
Characteristics tissue: immortalized cell line
developmental stage: derived from lymph node metastasis
concentration: 0.5uM PD
Treatment protocol Cells were seeded (without drugs) in standard culture media and treated for 24 hours with 0.5uM PD or vehicle control before harvesting RNA
Growth protocol Palbociclib (PD) resistant cells (PDR) were generated from LAPC4 and LNCaP cells via sustained treatment with 0.5uM PD and kept under PD-selection to maintain the cells. Parental cells were cultured in parallel in standard growth media.
Extracted molecule total RNA
Extraction protocol Total RNA was extracted with a RNeasy Mini Kit by Qiagen
RNA-seq from Illumina
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2500
 
Description LN-PDR1-PD_vs_LN-WT-PD.txt
LN-PDR2-PD_vs_LN-WT-PD.txt
LNWTPD_vs_LNWTCntrl.txt
Data processing Illumina Casava1.8 software used for basecalling.
Sequenced reads (fastq files) were trimmed for adaptor sequence, and masked for low-complexity or low-quality sequence
Secondary analysis was carried out on an OnRamp Bioinformatics Genomics Research Platform (OnRamp Bioinformatics, San Diego, CA). OnRampē—“ advanced Genomics Analysis Engine utilized an automated RNAseq workflow to process the data, including data validation and quality control and read alignment to the human genome (hg19) using blastx
The resulting SAM files were sorted and inputted into the Python package HTSeq to generate count data for gene-level differential expression analyses.
Transcript count data from DESeq2 analysis of the samples were sorted according to their adjusted p-value or q-value, which is the smallest false discovery rate (FDR) at which a transcript is called significant.
Genome_build: HG19
Supplementary_files_format_and_content: tab-delimited .txt files include DESEQ2 output for each Comparison ...
 
Submission date Jun 05, 2017
Last update date Mar 26, 2021
Contact name Gary Hardiman
E-mail(s) [email protected], [email protected], [email protected]
Organization name Medical University of South Carolina
Department Medicine
Street address 135 Cannon Street
City Charleston
State/province SC
ZIP/Postal code SC
Country USA
 
Platform ID GPL16791
Series (1)
GSE99675 CDK4/6 inhibitor resistance in prostate cancer
Relations
BioSample SAMN07194390
SRA SRX2883859

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap